Angiodynamics Inc (ANGO)
AngioDynamics makes medical devices for treating blood vessel conditions and cancer, sold mainly to hospitals and physicians. It last closed at $11.49 on Nov 17, down 2.46% on the day. ANGO reports earnings on Wed, Jan 6, 2027. The average 12-month price target from 2 analysts is $19.00 (+65.4% from the last close), with a high of $20.00 and a low of $18.00.
Key Stats
Last 12 monthsNot reported for this period.
From ANGO's SEC filings, latest 10-Q for the period ending Aug 31, 2026 (filed Oct 8). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 2 analysts who set a price target on ANGO in the past 90 days. The average target is $19.00, with a high of $20.00 and a low of $18.00, compared with the last close of $11.49.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 13 | HC Wainwright & Co. | Target lowered | Buy | $19 → $18 |
| Oct 9 | Canaccord Genuity | Maintained | Buy | $20 |
| Jul 15 | HC Wainwright & Co. | Maintained | Buy | $19 |
| Jul 15 | Canaccord Genuity | Maintained | Buy | $20 |
| Apr 7 | Freedom Broker | Initiated | Buy | $16 |
Technical Analysis
The stock is 5% below its 20 day and 16% below its 50 day average. It is 9% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 39). The nearest support is the Pivot S1 at $11.34, and the nearest resistance the Pivot at $11.56.
| RSI (14) | 38.70 | Weak, oversold below 30 | Neutral |
| MACD | -0.33 | Above its signal line | Bullish |
| Stochastic | 15.8 | Near the bottom of its range | Oversold |
| ADX (14) | 27.3 | Trending down | |
| Williams %R | -93.9 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -176.7 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −2.0% | Change over 10 sessions | Bearish |
| ATR (14) | $0.53 | Typical daily range, 4.6% of price |
| RSI (14) | 39.76 | Weak, oversold below 30 | Neutral |
| MACD | -0.23 | Below its signal line | Bearish |
| Stochastic | 19.0 | Near the bottom of its range | Oversold |
| ADX (14) | 28.1 | Trending down | |
| Williams %R | -84.7 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -100.4 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −24.8% | Change over 10 sessions | Bearish |
| ATR (14) | $1.16 | Typical daily range, 10.1% of price |
What happened before
See how ANGO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ANGO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
Whale Options Flow
90DNo whale options trades in ANGO in the last 90 days.
ANGO Institutional Ownership
Full report →- ▲96 buying vs 70 selling
- ▼Held by funds -2.8 pts
- ▲Funds holding +7
- ▼Superinvestors: 1 added, 3 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 171 | 164 | +4.3% |
| In funds' top 10 | 3 | 3 | 0.0% |
| Held by funds | 88.4% | 91.2% | −2.8 pts |
| New / increased | 32 / 64 | 31 / 55 | +11.6% |
| Reduced / sold out | 48 / 22 | 55 / 17 | −2.8% |
| Put/call ratio | – | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ANGO is in one of them and how their past ANGO trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ANGO in an article yet. Here's the latest on the wider market.
ANGO Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Debbie Wasserman SchultzD | Sell | $100K – $250K | Oct 20, 2025 | Oct 27, 2025 | 7 d |
| Debbie Wasserman SchultzD | Sell | $1K – $15K | Oct 20, 2025 | Oct 24, 2025 | 4 d |
| Debbie Wasserman SchultzD | Sell | $1K – $15K | Jul 16, 2025 | Jul 25, 2025 | 9 d |
| Debbie Wasserman SchultzD | Buy | $1K – $15K | Jun 27, 2025 | Jul 25, 2025 | 28 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Angiodynamics
AngioDynamics is a medical technology company based in Latham, New York. It designs, makes and sells medical devices that clinicians use to treat blood vessel conditions and cancer. Its products include systems for removing blood clots, catheters and guidewires used in diagnostic and treatment procedures, drainage products, and the NanoKnife system for tumor ablation. Hospitals and physicians are its main customers.
- Headquarters
- Latham, NY




